Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.63
-0.12 (-2.01%)
At close: May 9, 2025, 4:00 PM
5.63
0.00 (0.00%)
After-hours: May 9, 2025, 8:00 PM EDT
Serina Therapeutics Employees
As of December 31, 2024, Serina Therapeutics had 13 total employees, including 12 full-time and 1 part-time employees. The number of employees increased by 2 or 18.18% compared to the previous year.
Employees
13
Change (1Y)
2
Growth (1Y)
18.18%
Revenue / Employee
$3,923
Profits / Employee
-$72,231
Market Cap
55.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 2 | 18.18% |
| Dec 31, 2023 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SER News
- 1 day ago - Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 10 days ago - Serina Therapeutics to Present at JonesResearch Virtual CNS Day - GlobeNewsWire
- 24 days ago - Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting - GlobeNewsWire
- 3 months ago - Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewsWire